EXPO logo

Exponent, Inc. Stock Price

NasdaqGS:EXPO Community·US$3.4b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 6 Fair Values set on narratives written by author

EXPO Share Price Performance

US$65.28
-45.42 (-41.03%)
34.7% undervalued intrinsic discount
US$100.00
Fair Value
US$65.28
-45.42 (-41.03%)
34.7% undervalued intrinsic discount
US$100.00
Fair Value
Price US$65.28
AnalystHighTarget US$100.00
AnalystConsensusTarget US$88.00
AnalystLowTarget US$76.00

EXPO Community Narratives

AnalystHighTarget·
Fair Value US$100 33.4% undervalued intrinsic discount

Technological Complexity And Regulatory Demand Will Expand Consulting Markets

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value US$88 24.3% undervalued intrinsic discount

Rising Technological And Regulatory Demands Will Open New Markets

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AnalystLowTarget·
Fair Value US$76 12.4% undervalued intrinsic discount

Automation And Regulation Will Compress Margins Yet Offer Respite

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent EXPO News & Updates

Returns On Capital At Exponent (NASDAQ:EXPO) Have Stalled

Oct 06
Returns On Capital At Exponent (NASDAQ:EXPO) Have Stalled

A Look At The Fair Value Of Exponent, Inc. (NASDAQ:EXPO)

Jul 30
A Look At The Fair Value Of Exponent, Inc. (NASDAQ:EXPO)

When Should You Buy Exponent, Inc. (NASDAQ:EXPO)?

Jul 14
When Should You Buy Exponent, Inc. (NASDAQ:EXPO)?

Exponent (NASDAQ:EXPO) Knows How To Allocate Capital

Jun 28
Exponent (NASDAQ:EXPO) Knows How To Allocate Capital

Subdued Growth No Barrier To Exponent, Inc.'s (NASDAQ:EXPO) Price

May 27
Subdued Growth No Barrier To Exponent, Inc.'s (NASDAQ:EXPO) Price

Exponent, Inc. Key Details

US$519.2m

Revenue

US$333.6m

Cost of Revenue

US$185.6m

Gross Profit

US$82.7m

Other Expenses

US$102.8m

Earnings

Last Reported Earnings
Jul 04, 2025
Next Reporting Earnings
Oct 30, 2025
Earnings per share (EPS)
2.04
Gross Margin
35.74%
Net Profit Margin
19.81%
Debt/Equity Ratio
0%

Exponent, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet established dividend payer.

1 Risk
2 Rewards

About EXPO

Founded
1967
Employees
958
CEO
Catherine Corrigan
WebsiteView website
www.exponent.com

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The company provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. It also offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. In addition, the company provides proactive and reactive product safety, litigation support, and technical, regulatory services. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

U.S. Market Performance

  • 7 Days: 0.3%
  • 3 Months: 8.5%
  • 1 Year: 17.3%
  • Year to Date: 15.0%
Over the last 7 days, the market has remained flat, with no particular sector making any big moves this week. As for the longer term, the market has risen 17% in the past 12 months. Earnings are forecast to grow by 15% annually. Market details ›